Heme Oxygenase: A Target Gene for Anti-Diabetic and Obesity

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|14|5|412-421

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.5, 2008-01, pp. : 412-421

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Heme Oxygenase-1 as a Target for the Design of Gene and Pharmaceutical Therapies for Autoimmune Diseases

By  

Current Gene Therapy, Vol. 14, Iss. 3, 2014-06 ,pp. : 218-235

Bentham Science Publishers

Access to resources Recommend Favorite

Beta3 -Adrenoceptor Agonists as Anti-diabetic and Anti-obesity Drugs in Humans

By  

Current Pharmaceutical Design, Vol. 7, Iss. 14, 2001-09 ,pp. : 1433-1449

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Inflammatory Actions of the Heme Oxygenase-1 Pathway

By  

Current Pharmaceutical Design, Vol. 9, Iss. 30, 2003-11 ,pp. : 2541-2551

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Diabetic

By  

Current Bioactive Compounds, Vol. 2, Iss. 1, 2006-03 ,pp. : 86-87

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Diabetic

By  

Current Bioactive Compounds, Vol. 2, Iss. 3, 2006-09 ,pp. : 330-334

Bentham Science Publishers

Access to resources Recommend Favorite